ASXC Asensus Surgical

TransEnterix, Inc. is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. It offers the Senhance Surgical Robotic System, which offers robotic surgery for laparoscopic abdominal and pelvic surgery, as well as limited thoracic operations excluding cardiac and vascular surgery, and the SurgiBot System which refers to the a single-port, robotically enhanced laparoscopic surgical platform. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.
Company profile
Ticker
ASXC, TRXC, TRXDW
Exchange
Website
CEO
Anthony Fernando
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Boston Scientific • Baxter International • Becton, Dickinson And • 3M • Stryker • Teleflex • Resmed • Hill-Rom • Integra Lifesciences • Nuvasive ...
Former names
CELLULAR TECHNICAL SERVICES CO INC, SafeStitch Medical, Inc., TRANSENTERIX INC., TRANSENTERIX, INC.
SEC CIK
Corporate docs
IRS number
112962080
ASXC stock data
()
News
Press releases
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2020
11 Mar 21
TransEnterix, Inc. to Host Earnings Call
11 Mar 21
Asensus Surgical Announces Finalization of Name and Ticker Symbol Change
5 Mar 21
Asensus Surgical, Inc. Schedules Fourth Quarter and Fiscal Year 2020 Financial and Operating Results Conference Call for March 11, 2021
4 Mar 21
Asensus Surgical Announces FDA Clearance in General Surgery
3 Mar 21
Investment data
Securities sold
Number of investors
Calendar
11 Mar 21
13 Apr 21
31 Dec 21
Financial summary
Quarter (USD) |
Dec 20 | Sep 20 | Jun 20 | Mar 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) |
Dec 20 | Dec 19 | Dec 18 | Dec 17 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Financial data from company earnings reports.
Cash burn rate (estimated) | Burn method: Change in cash | Burn method: Operating income/loss | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 17.53M | 17.53M | 17.53M | 17.53M | 17.53M | 17.53M |
Cash burn (monthly) | 1.2M | (positive/no burn) | 4.64M | 5.08M | 4.26M | 3.89M |
Cash used (since last report) | 4.13M | n/a | 16.03M | 17.54M | 14.7M | 13.44M |
Cash remaining | 13.4M | n/a | 1.5M | -6.12K | 2.83M | 4.09M |
Runway (months of cash) | 11.2 | n/a | 0.3 | -0.0 | 0.7 | 1.1 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
31 Mar 21 | David Bruce Milne | Common Stock | Grant | Aquire A | No | No | 0 | 3,792 | 0 | 211,098 |
31 Mar 21 | Pfenniger Richard C JR | Common Stock | Grant | Aquire A | No | No | 0 | 4,242 | 0 | 80,474 |
31 Mar 21 | Starling William N JR | Stock Option Common Stock | Grant | Aquire A | No | No | 3.25 | 3,628 | 11.79K | 3,628 |
31 Mar 21 | Hsiao Jane PH D | Stock Option Common Stock | Grant | Aquire A | No | No | 3.25 | 3,155 | 10.25K | 3,155 |
31 Mar 21 | Biffi Andrea | Stock Option Common Stock | Grant | Aquire A | No | No | 3.25 | 3,155 | 10.25K | 3,155 |
Institutional ownership Q4 2020
Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.
8.6% owned by funds/institutions
13F holders |
Current |
---|---|
Total holders | 67 |
Opened positions | 12 |
Closed positions | 10 |
Increased positions | 15 |
Reduced positions | 10 |
13F shares |
Current |
---|---|
Total value | 12.55M |
Total shares | 20.08M |
Total puts | 144.23K |
Total calls | 902.6K |
Total put/call ratio | 0.2 |
Largest owners |
Shares | Value |
---|---|---|
Empery Asset Management | 6.45M | $4.03M |
Sabby Management | 4.99M | $3.12M |
Vanguard | 2.16M | $1.35M |
Renaissance Technologies | 1.43M | $892K |
Masters Capital Management | 900K | $562K |
Kepos Capital | 681.16K | $426K |
BLK Blackrock | 603.91K | $377K |
Millennium Management | 415.22K | $260K |
Geode Capital Management | 364.29K | $227K |
DB Deutsche Bank AG - Registered Shares | 288.6K | $180K |
Financial report summary
?Content analysis
?
Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accessibility, AdventHealth, age, ago, Aid, aim, Alexander, alliance, Amsterdam, Appendix, ASXC, Baptist, bariatric, benchmark, billion, bolstered, broader, call, calling, Canada, Canadian, captured, celebrate, Celebration, Centre, cessation, chain, Chairman, chart, chronic, Commonwealth, compensatory, complicated, composed, constantly, constrained, constraining, consumption, Continental, contributor, creative, culture, database, David, decade, deep, DEI, distancing, economy, employ, encourage, encouraged, enriched, envision, era, ethnicity, Exhibit, expert, female, filer, forgiven, formatted, foundation, foundational, frailty, gastrectomy, gender, goal, guaranty, guide, halted, harbor, heard, height, herewith, hiatal, holistically, home, Hsaio, ideal, inducement, Inline, insignificant, interaction, Jane, Jr, kicked, Kingdom, landlord, largest, LaViolette, Linkbase, lived, logical, lookback, Louisiana, LSU, Maastricht, Memic, mental, Milne, mission, neurodiversity, Nicholson, NOL, nominal, Ochsner, omitted, onsite, optimize, orientation, page, paraesophageal, passed, passionate, Paul, Paycheck, payroll, People, Pfenniger, pioneer, Pittsburgh, plaguing, poor, PPE, PPP, proctoring, progression, prompted, proportionate, race, Rampertab, ratifying, recommence, refocused, regained, regular, religion, remote, remotely, resonate, resubstitution, resurgence, Richard, Roszdravnadzor, Russia, Russian, Saitama, SBA, Schema, seamlessly, setup, sexual, Shameze, shocking, signatory, similarly, size, sized, skill, sleeve, society, sought, southeast, Southern, Specimen, standby, Starling, stead, strive, stronger, succeed, SurgeryTM, talent, tapping, Taxonomy, tenant, thereunto, therewith, thing, thrive, ticker, tied, timeline, top, Trust, TW, unadopted, undersigned, underwent, unissued, University, unlock, unlocking, unprecedented, unsatisfied, unsecured, urgency, valorem, vast, virtue, vital, webpage, William, XBRL
Removed:
achieved, added, Advancement, advantage, affecting, appeal, assuming, bankruptcy, clarify, Codification, combining, comparative, contact, contracting, convey, criterion, CSIMC, decreasing, deductible, Deferral, Distinguishing, embedded, entrance, existed, expended, foregoing, forma, gaining, incurrence, indefinite, indeterminate, indexed, Institute, intermediate, landscape, magnitude, Mandatorily, MINE, monetary, Morrisville, movement, nationwide, negotiation, Noncontrolling, Nonpublic, notice, objective, organization, Orlando, owe, pattern, PIPE, posture, preclude, principally, procedural, Pte, purport, receiving, Redeemable, reduction, refinancing, remeasured, repay, resale, revaluation, revalue, round, royalty, schedule, separability, spending, Stifel, strike, substantive, Synchrony, Synecor, thereon, unamortized, unaudited, unqualified
Financial reports
10-K
2020 FY
Annual report
11 Mar 21
10-Q
2020 Q3
Quarterly report
5 Nov 20
10-Q
2020 Q2
Quarterly report
5 Aug 20
10-Q
2020 Q1
Quarterly report
15 May 20
10-K
2019 FY
Annual report
16 Mar 20
10-Q
2019 Q3
Quarterly report
12 Nov 19
10-Q
2019 Q2
Quarterly report
8 Aug 19
10-Q
2019 Q1
Quarterly report
9 May 19
10-K
2018 FY
Annual report
27 Feb 19
10-Q
2018 Q3
Quarterly report
8 Nov 18
Current reports
8-K
Asensus Surgical, Inc. Reports Operating and Financial Results for the Fourth Quarter and Full Year 2020
12 Mar 21
8-K
Asensus Surgical Announces FDA Clearance in General Surgery
3 Mar 21
8-K
Amendments to Articles of Incorporation or Bylaws
25 Feb 21
8-K
Regulation FD Disclosure
23 Feb 21
8-K
Departure of Directors or Certain Officers
12 Feb 21
8-K
TransEnterix Announces $25 Million Bought Deal Offering of Common Stock
28 Jan 21
8-K
TransEnterix Receives CE Mark for Machine Vision System in Robotic Surgery
19 Jan 21
8-K
TransEnterix Announces $31.25 Million Registered Direct Offering of Common Stock
14 Jan 21
8-K
TransEnterix Provides Preliminary 2020 Year-End Corporate Update
6 Jan 21
8-K
TransEnterix Announces Southern Surgical Hospital to Initiate a Senhance® Digital Laparoscopic Program
17 Dec 20
Registration and prospectus
424B5
Prospectus supplement for primary offering
28 Jan 21
FWP
Free writing prospectus
27 Jan 21
FWP
Free writing prospectus
27 Jan 21
FWP
Free writing prospectus
26 Jan 21
424B5
Prospectus supplement for primary offering
26 Jan 21
424B5
Prospectus supplement for primary offering
14 Jan 21
S-8
Registration of securities for employees
5 Nov 20
424B5
Prospectus supplement for primary offering
9 Oct 20
424B5
Prospectus supplement for primary offering
1 Jul 20
424B5
Prospectus supplement for primary offering
30 Jun 20
Proxies
DEFA14A
Additional proxy soliciting materials
27 Apr 20
DEF 14A
Definitive proxy
27 Apr 20
DEFR14A
Revised proxy
18 Nov 19
PRE 14A
Preliminary proxy
5 Nov 19
DEF 14A
Definitive proxy
29 Oct 19
DEFA14A
Additional proxy soliciting materials
1 Apr 19
DEFA14A
Additional proxy soliciting materials
15 Mar 19
DEF 14A
Definitive proxy
15 Mar 19
DEF 14A
Definitive proxy
12 Apr 18
DEFA14A
Additional proxy soliciting materials
12 Apr 18
Other
EFFECT
Notice of effectiveness
28 May 20
CORRESP
Correspondence with SEC
21 May 20
UPLOAD
Letter from SEC
21 May 20
EFFECT
Notice of effectiveness
14 Feb 20
CORRESP
Correspondence with SEC
11 Feb 20
UPLOAD
Letter from SEC
11 Feb 20
EFFECT
Notice of effectiveness
11 Feb 20
UPLOAD
Letter from SEC
10 Feb 20
CORRESP
Correspondence with SEC
6 Feb 20
CT ORDER
Confidential treatment order
19 Sep 18
Ownership
4
ASENSUS SURGICAL / PAUL A LAVIOLETTE ownership change
2 Apr 21
4
ASENSUS SURGICAL / Andrea Biffi ownership change
2 Apr 21
4
ASENSUS SURGICAL / JANE PH D HSIAO ownership change
2 Apr 21
4
ASENSUS SURGICAL / William N Starling JR ownership change
2 Apr 21
4
ASENSUS SURGICAL / RICHARD C PFENNIGER JR ownership change
2 Apr 21
4
ASENSUS SURGICAL / David Bruce Milne ownership change
2 Apr 21
SC 13G/A
TRANSENTERIX / CVI Investments ownership change
16 Feb 21
4
TRANSENTERIX / Rampertab Shameze ownership change
8 Feb 21
4
TRANSENTERIX / Anthony C. J. Fernando ownership change
8 Feb 21
SC 13G/A
TRANSENTERIX / Empery Asset Management ownership change
28 Jan 21
Patents
APP
Utility
Instrument for Selectively Grabbing and Cutting Tissue
11 Feb 21
A surgical instrument configured for both grasping and cutting operations has a shaft with a push rod extending through it.
APP
Utility
Augmented Reality Using Eye Tracking In a Robot Assisted Srugical System
11 Feb 21
A system augments a surgical procedure by providing information to the user about regions of a surgical site the user is viewing on a displayed endoscopic image.
APP
Utility
Method and Apparatus for Optimizing Range of Motion of Two Robotic Arms In a Robotic Surgical System
11 Feb 21
A robotic manipulator system includes a base structure and a pair of manipulator arms on the base structure.
APP
Utility
Fingers-driven Haptic Interface for Robot-assisted Surgical System
11 Feb 21
A haptic interface for a robot-assisted surgical system makes use of a plurality of sensors and a plurality of bladders each mountable to fingers a human hand.
APP
Utility
Robot Assisted Surgical System with Clutch Assistance
11 Feb 21
A robot-assisted surgical system includes a robotic manipulator for robotic positioning of a surgical instrument, and a user input device moveable by a user to cause the robotic manipulator to move the surgical instrument.
Transcripts
2020 Q4
Earnings call transcript
12 Mar 21
2020 Q3
Earnings call transcript
5 Nov 20
2020 Q2
Earnings call transcript
5 Aug 20
2020 Q1
Earnings call transcript
14 May 20
2019 Q4
Earnings call transcript
16 Mar 20
2019 Q3
Earnings call transcript
12 Nov 19
2019 Q2
Earnings call transcript
7 Aug 19
2019 Q1
Earnings call transcript
9 May 19
2018 Q4
Earnings call transcript
26 Feb 19
2018 Q3
Earnings call transcript
8 Nov 18
Reddit threads
Daily Plays - April 12, 2021
12 Apr 21
High Risk/Reward
11 Apr 21
How I find and trade GOOD stocks every week thru finviz $AHCO $FUTU $GNLN $IHRT $PUBM $RXT
10 Apr 21
Waiting on that stock that's supposed to 'Go to the Moon'
10 Apr 21
Let me know what stocks you want to go green and I'll sell my shares! Works every time.
9 Apr 21
THE LOUNGE: thoughts, noob stuff, low effort, brokers, zero DD, non pennies - April 01, 2021
31 Mar 21
Where are you at on Biotech?
28 Mar 21
THE LOUNGE: thoughts, noob stuff, low effort, brokers, zero DD, non pennies - March 28, 2021
27 Mar 21
Picking Stock
26 Mar 21
Looking for good plays on options.
23 Mar 21